12:00 AM
Apr 17, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zadaxin thymosin alpha 1 immunomodulator regulatory update

South Korea granted marketing approval for Zadaxin as an influenza vaccine adjuvant...

Read the full 36 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >